PDCD1 and neoplasm: Cda overexpression in MC38 cells (Extended Data Fig. 4h,i) rendered the tumor more aggressive and resistant to anti-PD-1 therapy (Fig. 4d,e) as a result of impaired induction of a T cell response following anti-PD-1 administration.